0      0

Make vs Buy Business Analysis in Advanced Therapies

‐ Nov 6, 2020 10:30am

Credits: None available.

Make vs Buy Business Analysis in Advanced Therapies | In a moderated panel discussion, Project Farma details the considerations used in determining whether an advanced therapy company should manufacture therapies internally or utilize external third-party manufacturers. This discussion explores the rationale of gene and cell therapy companies using an external CMO or relying on internal manufacturing. With insight from one advanced therapy company that utilizes third party manufacturing, and another that manufactures internally, Project Farma provides the considerations for both cases along with perspective from a CMO regarding external manufacturing.



Credits: None available.

You must be logged in and own this session in order to post comments.